Orbital Therapeutics, a company dedicated to enhancing global health by unleashing the full potential of RNA medicines, today announced the appointmen ...

BioNTech's malaria vaccine trial faces an FDA clinical hold. The company is addressing concerns and collaborating with ...

Automation and artificial intelligence (AI) will be key to a new effort to manufacture millions of RNA vaccines in Africa.

CRISPR technology offers innovative solutions for pandemic preparedness, enhancing diagnostics, antiviral therapies, and ...

Novotech, the global full-service clinical CRO, has released its latest disease report: Hepatitis B - Global Clinical Trial ...

The mRNA vaccines that helped to end the COVID pandemic — and stoked a considerable amount of vaccine skepticism and ...

Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), and Civica, Inc. (Civica), a not-for-profit generic drug and ...

Chimerix is currently awaiting an FDA decision on accelerated approval of a drug it’s developing for a type of glioma.

Melanoma Companies are involved in targeted therapeutics development with respective active and inactive (dormant or ...

A new review article published in Genes & Diseases explores the intricate relationship between non-coding RNAs and oxidative stress in cancer progression shedding new light on the mechanisms that ...

Arrowhead (ARWR) announced presentation of preclinical data supporting the advancement of two clinical stage, RNAi-based investigational ...

There is no dearth of treatments that claim to hold back ageing. No magic pill exists that is proven to work - but we do know of some that might. It is an ancient dream of humankind - the dream of ...